Friend or Foe: MicroRNAs in the p53 network
- PMID: 29330109
- DOI: 10.1016/j.canlet.2018.01.013
Friend or Foe: MicroRNAs in the p53 network
Abstract
The critical tumor suppressor gene TP53 is either lost or mutated in more than half of human cancers. As an important transcriptional regulator, p53 modulates the expression of many microRNAs. While wild-type p53 uses microRNAs to suppress cancer development, microRNAs that are activated by gain-of-function mutant p53 confer oncogenic properties. On the other hand, the expression of p53 is tightly controlled by a fine-tune machinery including microRNAs. MicroRNAs can target the TP53 gene directly or other factors in the p53 network so that expression and function of either the wild-type or the mutant forms of p53 is downregulated. Therefore, depending on the wild-type or mutant p53 context, microRNAs contribute substantially to suppress or exacerbate tumor development.
Keywords: microRNA; p53.
Copyright © 2018. Published by Elsevier B.V.
Similar articles
-
MicroRNAs as Key Effectors in the p53 Network.Int Rev Cell Mol Biol. 2017;333:51-90. doi: 10.1016/bs.ircmb.2017.04.003. Epub 2017 May 22. Int Rev Cell Mol Biol. 2017. PMID: 28729028 Review.
-
p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.Mol Cancer Res. 2017 Aug;15(8):1051-1062. doi: 10.1158/1541-7786.MCR-17-0089. Epub 2017 May 8. Mol Cancer Res. 2017. PMID: 28483946 Free PMC article.
-
Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.FEBS Lett. 2014 Aug 19;588(16):2610-5. doi: 10.1016/j.febslet.2014.03.054. Epub 2014 Apr 12. FEBS Lett. 2014. PMID: 24726728 Free PMC article. Review.
-
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):a026054. doi: 10.1101/cshperspect.a026054. Cold Spring Harb Perspect Med. 2017. PMID: 27836911 Free PMC article. Review.
-
[miR-34s--a tumor suppression protein p53 highly related microRNA].Yi Chuan. 2010 May;32(5):423-30. doi: 10.3724/sp.j.1005.2010.00423. Yi Chuan. 2010. PMID: 20466628 Review. Chinese.
Cited by
-
Unraveling the mechanisms of glioblastoma's resistance: investigating the influence of tumor suppressor p53 and non-coding RNAs.Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2569-2585. doi: 10.1007/s00210-024-03564-z. Epub 2024 Oct 30. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39476245 Review.
-
Current and future perspectives on the regulation and functions of miR-545 in cancer development.Cancer Pathog Ther. 2023 Sep 5;2(3):142-154. doi: 10.1016/j.cpt.2023.09.001. eCollection 2024 Jul. Cancer Pathog Ther. 2023. PMID: 39027151 Free PMC article. Review.
-
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome.Nat Commun. 2020 Aug 7;11(1):3945. doi: 10.1038/s41467-020-17596-5. Nat Commun. 2020. PMID: 32770028 Free PMC article.
-
Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53.Molecules. 2024 Feb 4;29(3):725. doi: 10.3390/molecules29030725. Molecules. 2024. PMID: 38338471 Free PMC article.
-
Frequency of the TP53 R337H variant in sporadic breast cancer and its impact on genomic instability.Sci Rep. 2020 Oct 6;10(1):16614. doi: 10.1038/s41598-020-73282-y. Sci Rep. 2020. PMID: 33024147 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous